Outcomes of transcatheter device closure of hemodynamically significant PDA in neonates weighing < 3 kilograms

OBJECTIVES To demonstrate the safety and efficacy of transcatheter patent ductus arteriosus (PDA) device closure in neonates weighing ≤ 3 kilograms and to analyze its effect on respiratory status and growth. BACKGROUND Current management of hemodynamically significant PDA in premature neonates include medical closure, surgical ligation, and transcatheter device closure. Challenges include significant complications and, for medical closure, high failure rates. Techniques that increased complication risk impeded transcatheter methods. Increasing efforts at transcatheter closure are occurring, however, most are case reports and small, single center case series. METHODS From January 2015 to June 2019, all premature neonates ≤ 3 kg who underwent transcatheter PDA closure were retrospectively reviewed. RESULTS 94 device closures were performed on 91 patients with a median weight of 2.0 kg (0.90–3.0 kg). Procedural success was 99%. Complications included 3 device embolizations requiring retrieval. There was no procedural mortality. There was overall improvement in respiratory support represented by an average 0.17 decrease in the Pulmonary Score at a median of 69 days (1–333 days) (p = < 0.001). A corrected gestational age of < 34 weeks was associated with the highest proportion of patients with a decrease in Pulmonary Score. Growth velocity increased at four weeks post-procedure by 5.2 g/day (p = < 0.001) compared to two weeks pre-procedure. CONCLUSIONS With the availability of devices and techniques that enable delivery in small neonates, transcatheter PDA closure is an effective and low morbidity alternative to traditional therapies with improvement in respiratory status and growth.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11641247/v1
Primary Topic
Cardiovascular Conditions and Treatments
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Outcomes of transcatheter device closure of hemodynamically significant PDA in neonates weighing < 3 kilograms

John P. Breinholt, Chandra Srinivasan, Li Xiong
Research Square
Cardiovascular Conditions and Treatments
preprint

Outcomes of transcatheter device closure of hemodynamically significant PDA in neonates weighing < 3 kilograms

John P. Breinholt, Chandra Srinivasan, Li Xiong
preprint en

Abstract

OBJECTIVES To demonstrate the safety and efficacy of transcatheter patent ductus arteriosus (PDA) device closure in neonates weighing ≤ 3 kilograms and to analyze its effect on respiratory status and growth. BACKGROUND Current management of hemodynamically significant PDA in premature neonates include medical closure, surgical ligation, and transcatheter device closure. Challenges include significant complications and, for medical closure, high failure rates. Techniques that increased complication risk impeded transcatheter methods. Increasing efforts at transcatheter closure are occurring, however, most are case reports and small, single center case series. METHODS From January 2015 to June 2019, all premature neonates ≤ 3 kg who underwent transcatheter PDA closure were retrospectively reviewed. RESULTS 94 device closures were performed on 91 patients with a median weight of 2.0 kg (0.90–3.0 kg). Procedural success was 99%. Complications included 3 device embolizations requiring retrieval. There was no procedural mortality. There was overall improvement in respiratory support represented by an average 0.17 decrease in the Pulmonary Score at a median of 69 days (1–333 days) (p = < 0.001). A corrected gestational age of < 34 weeks was associated with the highest proportion of patients with a decrease in Pulmonary Score. Growth velocity increased at four weeks post-procedure by 5.2 g/day (p = < 0.001) compared to two weeks pre-procedure. CONCLUSIONS With the availability of devices and techniques that enable delivery in small neonates, transcatheter PDA closure is an effective and low morbidity alternative to traditional therapies with improvement in respiratory status and growth.

Research Square
Children's Hospital of Philadelphia (US), Penn State Health Children's Hospital (US), The University of Texas Health Science Center at Houston (US)
Cardiovascular Conditions and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon